April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28…
New York City, Nov. 29, 2025 (GLOBE NEWSWIRE) -- November 28, 2025, CrazyBulk, a leading provider of Anabolic steroid alternatives,…
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST November 02, 2025 19:00 ET |…
August 20, 2025 09:48 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…
In competitive bodybuilding, muscular endurance can be the deciding factor between finishing strong or hitting an early wall. While strength…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…